Dr. Ranjana Bhandari

1) Business Model of Company: The startup company is a Generic discovery company with an objective to discover and develop therapies of established drug by value addition. This will include but not limited to:

• Value addition in existing products (super generics)
• Repurposing of established molecules
• Delivering by alternate routes to improve therapeutic value.
• Novel drug delivery systems
• Nutraceuticals

2) Developed high-performing teams by providing mentorship, guidance, and opportunities for professional growth.

3) Implemented innovative solutions to solve complex problems, resulting in increased productivity and streamlined operations.

Projects Handled by Company:

Projects Undertaken/Technologies Developed/Ongoing:

1) Received BIG-BIRAC grant worth 50 Lakhs for the project entitled” A novel chewable gel, a platform technology with application in Autistic children”

Safe, inexpensive platform technology. Patient compliance due to its flavor, aesthetic appeal, citrus and fruity taste. Option of altering dose strength and dosage regimen Best Platform technology for pediatric, geriatric and patients with dysphagia. One of its kind for autistic patients and can help in achieving compliance to their regimen I have recently got the BIG BIRAC grant (20th call ) of 50 Lakhs for this technology. After completion of POC, we would be transferred to the industry. Filed a patent application with patent number 202211035087 , the patent title “A Pharmaceutical Formulation, Its Method of Preparation And Use Thereof”

2) A Process to Prepare Naringenin Nanocarriers for Autism Spectrum Disorders

-Patent has been filed and published as well. It is under examination stage. We will soon be licensing this technology to the industry

3) TOPICAL FORMULATION FOR TREATMENT OF NEUROPATHIC PAIN: Received Australian Innovation Patent; Indian Patent Filed :

Fastest pain relief due to targeted/facilitated & synergistic effect. Patient compliance due to: significantly superior efficacy/ Complete pain relief OD application Negligible side-effects profile because of targeted action We are developing this technology and would be soon licencing out this technology to industry.

Received Pfizer-IIT Delhi Innovation IP Grant (grant for filing of the technology patent for above proposal)

Title: “Development of novel targeted nanogel for diabetes & Cancer-Chemotherapy induced

neuropathic pain” (Filing of Patent Application)

• Till date Granted 1 Australian Patent, 3 Indian Patents filed

1) Teaching Subjects-Taking B.Pharm & M.Pharm Theory as well as Practical classes:

• Pharmaceutical Engineering (Theory & Practical), Advanced Biopharmaceutics & Pharmacokinetics, Drug Delivery. I have my corecompetancy in pharmacokinetics, biopharmaceutics, drug delivery and PKPD correlation

2) Mentored students and communicated internship and employment opportunities.

3) Contributed to departmental goals by serving on various committees focused on curriculum development, assessment strategies, and accreditation requirements.

4) Inspired critical thinking skills among students by fostering a learning environment that encouraged open-mindedness, curiosity, and intellectual exploration.

5) Established strong partnerships with other institutions via collaborative research projects or exchange programs that benefited both faculty members'' professional development as well as student learning experiences globally.

Research Projects undertaken:

1) Granting Agency: International brain Research Organization (IBRO)

Title: Brain-targeted nanocarriers for Autism Spectrum Disorders-5000 $

2) 2A) Role: Co-Principle-Investigator

Time Period: 1 year

Granting Agency: Department of Science & Technology-Chandigarh Administration, India

Title: A novel healthcare solution for diabetes and cancer neuropathic pain patients Amount: 2700 USD

• Completed research, compiled data, and assisted in timely reporting.
• Visualised research findings through data tables, graphs and presentations.

AI- work:

• Bioinformatics, Chemoinformatics, Computer-Aided Drug Designing, and Molecular Dynamic Simulation (Certificates Attached).
• Completed Research Project entitled "Pharmacophore Modelling, Virtual Screening, Molecular Dynamic simulation of Novel Inhibitors for Receptor Tyrosine Kinase in the Treatment of Glioblastoma"
• Next-Generation Sequencing Data Analysis & Python as well as Biopython.

Patent Law & Drafting: Learnt about Indian Patent Lw, Intellectual Property, Patent filing procedure, Patent drafting, claim drafting